To date, five DDD children have a diagnostic variant in one of these treatable ID genes (DHCR7, IVD, LMBRD1, MTR, and SLC2A1) and might be suitable for either dietary restriction, supplementation, or pharmacological intervention. This evidence concerns the gene MTR and Dowling-Degos disease 1.